Hoping for Allies Among Trump’s Health Picks, Pharma Faces Hostility
Health
By Rebecca Robbins, Christina Jewett and Kate Kelly from NYT Health https://ift.tt/zSUO9Ek
via IFTTT Drugs (Pharmaceuticals), Regulation and Deregulation of Industry, Appointments and Executive Changes, Vaccination and Immunization, United States Politics and Government, Presidential Election of 2024, Presidential Transition (US), Prices (Fares, Fees and Rates), Lobbying and Lobbyists, Stocks and Bonds, Coronavirus (2019-nCoV), Dietary Supplements and Herbal Remedies, Biotechnology and Bioengineering, Health Insurance and Managed Care, Medicare, Politics and Government, Medicine and Health, Medicaid Robert F. Kennedy Jr. and other candidates for top health posts are at odds with the drug industry, setting the stage for tense battles over regulatory changes.

By Rebecca Robbins, Christina Jewett and Kate Kelly from NYT Health https://ift.tt/zSUO9Ek
via IFTTT Drugs (Pharmaceuticals), Regulation and Deregulation of Industry, Appointments and Executive Changes, Vaccination and Immunization, United States Politics and Government, Presidential Election of 2024, Presidential Transition (US), Prices (Fares, Fees and Rates), Lobbying and Lobbyists, Stocks and Bonds, Coronavirus (2019-nCoV), Dietary Supplements and Herbal Remedies, Biotechnology and Bioengineering, Health Insurance and Managed Care, Medicare, Politics and Government, Medicine and Health, Medicaid Robert F. Kennedy Jr. and other candidates for top health posts are at odds with the drug industry, setting the stage for tense battles over regulatory changes.
Comments
Post a Comment